Genetic and familial aspects of narcolepsy

Neurology

Volumn 50, Issue 2 SUPPL.1, 1998, Pages

  Mignot, Emmanuel ^a,b  

^a Stanford California and Cofounder   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CLONING; DOG; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MONOZYGOTIC TWINS; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; RELATIVE;

EID: 0031912090     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.50.2_suppl_1.s16     Document Type: Article

References (71)

1. Aldrich MS. Narcolepsy. Neurology 1992;42(suppl 6):34-43.
2. Solomon P, Narcolepsy in Negroes. Dis Nerv Syst 1945;6:179-183.
3. Roth B. Narcolepsy and hypersomnia. Basel: Karger, 1980.
4. Dement W, Zarcone V, Varner V, et al. The prevalence of narcolepsy [abstract]. Sleep Res 1972;1:148.
5. Dement WC, Carskadon M, Ley R. The prevalence of narcolepsy II [abstract]. Sleep Res 1973;2:147.
6. Honda Y. Census of narcolepsy, cataplexy and sleep life among teen-agers in Fujisawa city [abstract]. Sleep Res 1979; 8:191.
7. Lavie P, Peled R. Narcolepsy is a rare disorder in Israel [letter]. Sleep 1987;10:608-609.
8. Hublin C, Kaprio J, Partinen M, et al. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol 1994;35:709-716.
9. Tashiro T, Kanbayashi T, Hishikawa Y. An epidemiological study of narcolepsy in Japanese [abstract]. Proceedings of the 4th International Symposium on Narcolepsy; Tokyo, Japan, June 16-17, 1994;13.
10. Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatr 1996;169:459-467.
11. Westphal C. Eigenthümliche mit Einschläfen verbundene Anfälle. Arch Psychiatr 1877;7:622-635.
12. Baraitser M, Parkes JD. Genetic study of the narcoleptic syndrome. J Med Genet 1978;15:254-259.
13. Kessler S, Guilleminault C, Dement W. A family study of 50 REM narcoleptics. Acta Neurol Scand 1974;50:503-512.
14. Yoss RE, Daly DD. Hereditary aspects of narcolepsy. Trans Am Neurol Assoc 1960;85:239-240.
15. Mignot E, Guilleminault C, Dement WC, Grumet FC. Genetically determined animal models of narcolepsy, a disorder of REM sleep. In: Driscoll D, ed. Genetically defined animal models of neurobehavioral dysfunctions. Cambridge: Birkhauser Boston, 1992:90-110.
16. Mignot E, Wang C, Rattazzi C, et al. Genetic linkage of autosomal recessive canine narcolepsy with an immunoglobulin μ chain switch-like segment. Proc Natl Acad Sci USA 1991;88: 3475-3478.
17. Kessler S. Genetic factors in narcolepsy. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum, 1976:285-302.
18. Kales A, Cadieux RJ, Soldatos CR, et al. Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics. Arch Neurol 1982;39:164-168.
19. Honda Y, Asaka A, Tanimura M, Furusho T. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology and long-term evolution. New York: Raven Press, 1983;187-199.
20. Guilleminault C, Mignot E, Grumet C. Family patterns of narcolepsy. Lancet 1989;11:1376-1380.
21. Billiard M, Pasquié-Magnetto V, Heckman M, et al. Family studies in narcolepsy. Sleep 1994;17:S54-S59.
22. Nevsimalova S, Mignot E, Sonka K, Arrigoni J. Familial aspects of narcolepsy-cataplexy in the Czech Republic. Sleep (in press).
23. D'Alessandro R, Rinaldi R, Cristina E, Gamberini G, Lugaresi E. Prevalence of excessive daytime sleepiness: an open epidemiological problem. Sleep 1995;18:389-391.
24. Imlah NW. Narcolepsy in identical twins. J Neurol Neurosurg Psychiatr 1961;24:158-160.
25. Mitchell S, Cummins L. Idiopathic narcolepsy in one of monozygotic twins [abstract]. Proceedings of the meeting of the Association for the Psychophysiological Study of Sleep, Washington, DC, 1965.
26. Honda Y, Matsuki K. Genetic aspects of narcolepsy. In: Thorpy MJ, ed. Handbook of sleep disorders. New York: Marcel Dekker, 1990:217-234.
27. Mamelak M, Caruso VJ, Stewart K. Narcolepsy: a family study. Biol Psychiatr 1979;14:821-834.
28. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980;30:105-108.
29. Asaka A, Honda Y, Takahashi Y. Two pairs of monozygotic twins completely discordant for narcolepsy. Proceedings of the 7th International Congress of Human Genetics, Sendai, Japan, 1986.
30. Montplaisir J, Poirier G. Narcolepsy in monozygotic twins. Neurology 1987;37:1089.
31. Douglas AB, Harris L, Pazderka F. Monozygotic twins concordant for the narcoleptic syndrome. Neurology 1989;39:140-141.
32. Pollmächer T, Schulz H, Geisler P, Kiss E, Albert ED, Schwarzfischer F. DR2-positive monozygotic twins discordant for narcolepsy. Sleep 1990;13:336-343.
33. Hayduk R, Flodman P, Spence MA, Erman MK, Mitler MM. Monozygotic twins with narcolepsy: preliminary report [abstract]. Sleep Res 1996;25:252.
34. Dahlitz MJ, Vaughan R, Leenders KL, Kahn N, Parkes JD. Twin studies in the narcoleptic syndrome [abstract]. J Sleep Res 1994;3(suppl 1):54.
35. Dablitz MJ, Gurling N, Kahn N, Leenders KL, Parkes JD. Family linkage and twin studies in the narcoleptic syndrome [abstract]. Proceedings of the 4th International Symposium on Narcolepsy; Tokyo, Japan, June 16-17, 1994:17-18.
36. Parkes JD, Dahlitz MJ. Genetic and twin studies in the narcoleptic syndrome [abstract]. J Sleep Res 1996;5(suppl 1):166.
37. Honda Y, Asaka A, Tanaka Y, Juji T. Discrimination of narcolepsy by using genetic markers and HLA [abstract]. Sleep Res 1983;12:254.
38. Doran T, Rouse S, Hakos G, Honeyman M. FT31 may demonstrate & DQw1 variant in narcoleptic patients. In: Aizawa M, ed. HLA in Asia-Oceania 1986. Sapporo, Japan: Hokkaido University Press, 1986:783-786.
39. Langdon N, Welch KI, van Dam M, Vaughan RW, Parkes DJ. Genetic markers in narcolepsy. Lancet 1984;2:1178-1180.
40. Billiard M, Seignalet J. Extraordinary association between HLA-DR2 and narcolepsy. Lancet 1985;1:226-227.
41. Poirier G, Montplaisir J, Décary F, Momège D, Lebrun A. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. Sleep 1986;9:153-158.
42. Meier-Ewert K, Mueller-Eckhardt G, Schendel DJ. Narcolepsy and HLA in the Federal Republic of Germany: population and family data. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer-Verlag, 1988:114-120.
43. Rogers AE, Mehan J, Guilleminault C, Grumet FC, Mignot E. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 1997;48:1550-1556.
44. Neely SE, Rosenberg RS, Spire JP, Antel J, Arnason BGW. HLA antigens in narcolepsy. Neurology 1987;37:1858-1860.
45. Mignot E, Lin X, Arrigoni J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and Black Americans. Sleep 1994;17:S60-S67.
46. Mignot E, Hayduk R, Black J, Grumet FC, US Modafinil in Narcolepsy Study Group, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20 (in press).
47. Matsuki K, Honda Y, Juji T. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies. Tissue Antigens 1987;30:155-160.
48. Mignot E, Kimura A, Lattermann A, et al. HLA class II studies in non DRB1*1501 patients with narcolepsy-cataplexy. In: Charon D, Fauchet R, eds. HLA 1996, Proceedings of the 12th International Histocompatibility Workshop and Conference. Genetic diversity of HLA: functional and medical implications. Vol. 1. Paris: EDK Press [in press].
49. Mignot E, Kimura A, Lattermann A, et al. Extensive HLA class II studies in 58 non DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens. 1979;49:329-341.
50. Parkes JD, Langdon N, Lock C. Narcolepsy and immunity. BMJ 1986;292:359-360.
51. Carlander B, Eliaou JF, Billiard M. Autoimmune hypothesis in narcolepsy. Neurophysiol Clin 1993;23:15-22.
52. Mignot E, Tafti M, Dement WC, Grumet FC. Narcolepsy and immunity. Adv Neuroimmunol 1995;5:23-37.
53. Fredrikson S, Carlander B, Billiard M, Link H. CSF immune variable in patients with narcolepsy. Acta Neurol Scand 1990; 81:253-254.
54. Matsuki K, Honda Y, Satake M, Juji T. HLA in narcolepsy in Japan. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer-Verlag, 1988:58-75.
55. Rubin RL, Hajdukovich RM, Mitler MM. HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin Immunol Imunopathol 1988; 49:149-158.
56. Erlich SS, Itabashi HH. Narcolepsy: a neuropathologic study. Sleep 1986;9:126-132.
57. Mignot E, Lister E, Burnett R, et al. Bone marrow transplantation studies in canine narcolepsy [abstract]. Sleep Res 1995; 24:297.
58. Tafti M, Nishino S, Aldrich MS, Liao W, Dement WC, Mignot E. Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in a canine model. J Neurosci 1996;16:4588-4595.
59. Lock CB, So AKL, Welch KI, Parkes JD, Trowsdale J. MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 1988;27:449-455.
60. Uryu N, Maeda M, Nagata Y, et al. No difference in the nucleotide sequence of the DQB β1 domain between narcoleptic and healthy individuals with DR2,Dw2. Hum Immunol 1989;24:175-181.
61. Guilleminault C, Grumet C. HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2. Hum Immunol 1986; 17:1-2.
62. Mueller-Eckhardt G, Meier-Ewert K, Schendel DJ, Reinecker FB, Muthoff G, Mueller-Eckhardt C. HLA and narcolepsy in a German population. Tissue Antigens 1986;28:163-169.
63. Andreas-Zietz A, Keller E, Scholz S, et al. DR2-negative narcolepsy. Lancet 1986;2:684-685.
64. Mignot E, Lin X, Kalil J, et al. DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics. Sleep 1992; 15:415-422.
65. Singh SM, George CFP, Kryger MH, Jung JH. Genetic heterogeneity in narcolepsy. Lancet 1990;335:726-727.
66. Mignot E, Meehan J, Grumet FC, et al. HLA class II and narcolepsy in thirty-three multiplex families [abstract]. Sleep Res 1996;25:303.
67. Dutra AS, Mignot E, Puck JM. Gene localization and syntenic mapping by FISH in the dog. Cytogenet Cell Genet 1996;74: 113-117.
68. Perry VH, Andersson P-B, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci 1993;16:268-273.
69. Yamamori T, Fukada K, Aebersold R, Korsching S, Fann M-J, Patterson PH. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 1989;246:1412-1416.
70. Schöbitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 1994;44:397-432.
71. Krueger JM, Karnovsky ML. Sleep as a neuroimmune phenomenon: a brief historical perspective. Adv Neuroimmunol 1995;5:5-12.